$ODYS
Odysight.ai Inc. Stock $odys

$odys Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224011341 Filed on March 26, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$187.0K	$1.946M	$3.033M
YoY Change	-38.28%	1123.9%	356.09%
Cost Of Revenue	$410.0K	$876.0K	$2.524M
YoY Change	-25.45%	148.86%	54.75%
Gross Profit	-$223.0K	$1.070M	$509.0K
YoY Change	-9.72%	-654.4%	-152.69%
Gross Profit Margin	-119.25%	54.98%	16.78%
Selling, General & Admin	$1.574M	$1.438M	$5.540M
YoY Change	38.8%	262.22%	29.56%
% of Gross Profit		134.39%	1088.41%
Research & Development	$1.567M	$1.495M	$5.602M
YoY Change	12.09%	27.34%	33.48%
% of Gross Profit		139.72%	1100.59%
Depreciation & Amortization	$33.00K	$45.00K	$284.0K
YoY Change	-78.71%	-50.55%	13.15%
% of Gross Profit		4.21%	55.8%
Operating Expenses	$3.141M	$2.943M	$11.14M
YoY Change	24.05%	88.17%	31.5%
Operating Profit	-$3.364M	-$1.873M	-$10.63M
YoY Change	21.05%	6.6%	12.65%
Interest Expense	$202.0K	$332.0K	$988.0K
YoY Change	134.88%	256.99%	-1774.58%
% of Operating Profit
Other Income/Expense, Net		$200.0K	$200.0K
YoY Change
Pretax Income	-$3.162M	-$1.341M	-$9.445M
YoY Change	17.72%	-19.41%	-0.24%
Income Tax
% Of Pretax Income
Net Earnings	-$3.162M	-$1.341M	-$9.445M
YoY Change	17.72%	-19.41%	-0.24%
Net Earnings / Revenue	-1690.91%	-68.91%	-311.41%
Basic Earnings Per Share	$0.30		-$0.98
Diluted Earnings Per Share	$0.30	-$0.13	-$0.98
COMMON SHARES
Basic Shares Outstanding	10.45M shares	10.44M shares	9.668K shares
Diluted Shares Outstanding	10.45K shares		9.668K shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.59M	$17.04M	$17.04M
YoY Change	-36.6%	29.63%	29.63%
Cash & Equivalents	$7.362M	$8.945M	$8.945M
Short-Term Investments	$8.228M	$8.096M	$8.096M
Other Short-Term Assets	$562.0K	$432.0K	$432.0K
YoY Change	-0.35%	53.74%	53.74%
Inventory	$604.0K	$504.0K	$504.0K
Prepaid Expenses
Receivables	$123.0K	$1.372M	$1.372M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.19M	$19.35M	$19.35M
YoY Change	-33.65%	37.06%	37.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$466.0K	$477.0K	$1.857M
YoY Change	-8.27%	-26.39%	94.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$96.00K	$96.00K	$367.0K
YoY Change	-64.18%	-70.73%	11.89%
Total Long-Term Assets	$3.352M	$3.480M	$3.480M
YoY Change	31.09%	25.27%	25.27%
TOTAL ASSETS
Total Short-Term Assets	$17.19M	$19.35M	$19.35M
Total Long-Term Assets	$3.352M	$3.480M	$3.480M
Total Assets	$20.54M	$22.83M	$22.83M
YoY Change	-27.83%	35.12%	35.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$399.0K	$287.0K	$287.0K
YoY Change	9.32%	-3.37%	-3.37%
Accrued Expenses	$1.371M	$1.016M	$1.016M
YoY Change	45.39%	30.59%	30.59%
Deferred Revenue	$557.0K	$527.0K
YoY Change	-57.29%	-63.04%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.670M	$2.082M	$2.082M
YoY Change	1.91%	-18.64%	-18.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$28.00K	$2.940M
YoY Change		-98.9%	15.29%
Total Long-Term Liabilities	$2.726M	$2.940M	$2.940M
YoY Change	10.45%	15.29%	15.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.670M	$2.082M	$2.082M
Total Long-Term Liabilities	$2.726M	$2.940M	$2.940M
Total Liabilities	$5.396M	$5.022M	$5.022M
YoY Change	6.05%	-1.7%	-1.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.40M	-$34.20M
YoY Change	36.26%	38.11%
Common Stock	$52.51M	$52.01M
YoY Change	3.33%	42.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.15M	$17.81M	$17.81M
YoY Change
Total Liabilities & Shareholders Equity	$20.54M	$22.83M	$22.83M
YoY Change	-27.83%	35.12%	35.12%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$3.162M	-$1.341M	-$9.445M
YoY Change	17.72%	-19.41%	-0.24%
Depreciation, Depletion And Amortization	$33.00K	$45.00K	$284.0K
YoY Change	-78.71%	-50.55%	13.15%
Cash From Operating Activities	-$1.230M	-$2.671M	-$10.01M
YoY Change	-50.28%	34.36%	64.22%
INVESTING ACTIVITIES
Capital Expenditures	$22.00K	$19.00K	$113.0K
YoY Change	46.67%	-38.71%	-4.24%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$4.500M	-$5.000M
YoY Change	-100.0%	-147.37%	-162.5%
Cash From Investing Activities	-$22.00K	-$4.519M	-$5.113M
YoY Change	-99.82%	-147.72%	-164.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-26.00K	$13.81M
YoY Change
NET CHANGE
Cash From Operating Activities	-$1.230M	-2.671M	-$10.01M
Cash From Investing Activities	-$22.00K	-4.519M	-$5.113M
Cash From Financing Activities		-26.00K	$13.81M
Net Change In Cash	-$1.252M	-7.216M	-$1.313M
YoY Change	144.53%	-196.46%	-173.48%
FREE CASH FLOW
Cash From Operating Activities	-$1.230M	-$2.671M	-$10.01M
Capital Expenditures	$22.00K	$19.00K	$113.0K
Free Cash Flow	-$1.252M	-$2.690M	-$10.12M
YoY Change	-49.7%	33.23%	62.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001577445
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023	SCTC	Interest And Exchange Differences From Operating Lease Liability InterestAndExchangeDifferencesFromOperatingLeaseLiability		usd
CY2022	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022	SCTC	Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations		usd
CY2022Q4	SCTC	Government Authorities GovernmentAuthorities		usd
CY2022Q4	SCTC	Other Payables OtherPayables		usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2023	SCTC	Contract With Customer Liability Deferred Revenue Relating To New Sales ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales		usd
CY2023	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability		usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	333-188920
CY2023	dei	Entity Registrant Name EntityRegistrantName	ODYSIGHT.AI INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-4257143
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Suite 7A
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Industrial Park
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	P.O. Box 3030
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Omer
CY2023	dei	Entity Address Country EntityAddressCountry	IL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	8496500
CY2023	dei	City Area Code CityAreaCode	+972
CY2023	dei	Local Phone Number LocalPhoneNumber	73 370-4690
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	11090000.00	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10446685	shares
CY2023	dei	Auditor Firm AuditorFirmId	1197
CY2023	dei	Auditor Name AuditorName	Brightman Almagor Zohar & Co
CY2023	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8945000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10099000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	8096000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	3047000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1372000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	504000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	630000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	432000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	281000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	19349000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14117000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1256000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1495000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	477000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	648000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1380000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	307000	usd
CY2023Q4	SCTC	Severance Pay Asset SeverancePayAsset	271000	usd
CY2022Q4	SCTC	Severance Pay Asset SeverancePayAsset	328000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	96000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3480000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2778000	usd
CY2023Q4	us-gaap	Assets Assets	22829000	usd
CY2022Q4	us-gaap	Assets Assets	16895000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	287000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	297000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	527000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1426000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	470000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	199000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	546000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	365000	usd
CY2023Q4	SCTC	Account Payable Other Current AccountPayableOtherCurrent	211000	usd
CY2022Q4	SCTC	Account Payable Other Current AccountPayableOtherCurrent	214000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2082000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2559000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1795000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2218000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	856000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	64000	usd
CY2023Q4	SCTC	Liability For Severance Pay LiabilityForSeverancePay	261000	usd
CY2022Q4	SCTC	Liability For Severance Pay LiabilityForSeverancePay	268000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2940000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2550000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5022000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5109000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10443768	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10443768	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7121737	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7121737	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	52004000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36541000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34207000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24762000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	17807000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22829000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16895000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3033000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	665000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	2524000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1631000	usd
CY2023	us-gaap	Gross Profit GrossProfit	509000	usd
CY2022	us-gaap	Gross Profit GrossProfit	-966000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4431000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3577000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-10633000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-9439000	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	200000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	30000	usd
CY2023	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	988000	usd
CY2022	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	-59000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9445000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9468000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9445000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9468000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9668	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9668	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7122	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7122	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1664000	usd
CY2023	SCTC	Stock Issued During Period Value Of Shares And Warrants StockIssuedDuringPeriodValueOfSharesAndWarrants	13802000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9445000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	17807000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19616000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19616000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1638000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9468000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9445000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9468000	usd
CY2023	us-gaap	Depreciation Depreciation	284000	usd
CY2022	us-gaap	Depreciation Depreciation	251000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1664000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1638000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	159000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-269000	usd
CY2022	SCTC	Interest And Exchange Differences From Operating Lease Liability InterestAndExchangeDifferencesFromOperatingLeaseLiability	49000	usd
CY2023	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability	-50000	usd
CY2022	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability	8000	usd
CY2023	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	49000	usd
CY2022	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	34000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1312000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	52000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-126000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	463000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-391000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-233000	usd
CY2023	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	381000	usd
CY2022	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	261000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	247000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-162000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-10000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	194000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-239000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-180000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1322000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1224000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	181000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	10000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	17000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-19000	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	18000	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	4000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10009000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6095000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	113000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	118000	usd
CY2023	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits	21500000	usd
CY2022	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits	14500000	usd
CY2023	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits	26500000	usd
CY2022	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits	6500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5113000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7882000	usd
CY2023	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants	13809000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13809000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1313000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1787000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10099000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8581000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	159000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-269000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8945000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10099000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1506000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	155000	usd
CY2023	SCTC	Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations	-52000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80D_eus-gaap--NatureOfOperations_zuIRDP4dWBF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b>NOTE 1 – <span><span id="xdx_82D_zBBWoDUe14hk">GENERAL</span>:</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Odysight.ai Inc (the “Company”), formerly known as ScoutCam Inc., was incorporated under the laws of the State of Nevada on March 22, 2013. Prior to the closing of the Exchange Agreement (as defined below), the Company was a non-operating “shell company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 5, 2023, the Company filed with the Nevada Secretary of State a Certificate of Amendment to the Registrant’s Articles of Incorporation to change its name from “ScoutCam Inc.” to “Odysight.ai Inc.”, effective June 5, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned subsidiary, Odysight.ai Ltd (“Odysight.ai”), formerly known as ScoutCam Ltd., was formed in the State of Israel on January 3, 2019, as a wholly-owned subsidiary of Medigus Ltd. (“Medigus”), an Israeli company traded on the Nasdaq Capital Market, and commenced operations on March 1, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2019, Medigus and Odysight.ai consummated an asset transfer agreement, under which Medigus transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business to Odysight.ai.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 30, 2019, the Company and Medigus consummated a securities exchange agreement (the “Exchange Agreement”), pursuant to which Medigus delivered <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20191230__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MedigusMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zZMgD93RrKA2" title="Ownership percentage">100</span>% of its holdings in Odysight.ai to the Company in exchange for shares of the Company’s common stock representing <span id="xdx_90A_ecustom--PercentageOfExchangeForSharesIssuedAndOutstandingShareCapital_pid_dp_uPure_c20191230__20191230__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MedigusMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_z5Binvyd7gve" title="Percentage of exchange for shares issued and outstanding share capital">60</span>% of the issued and outstanding share capital of the Company immediately upon the consummation of the Exchange Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2020-2023 Medigus decreased its holdings in the Company such that as of March 31, 2023, Medigus owned <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MedigusMember_zIFS4qutcjx9">18.45</span>% of the Company’s outstanding common stock. On June 1, 2023, Medigus sold all of its holdings in the Company to existing shareholders and to Chairman of the Board and CEO of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2024, D. VIEW Ltd. was formed in the State of Israel, wholly owned by Odysight.ai Inc., to act as a local agent for the defense market in Israel.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through Odysight.ai, provides image-based platforms. Through the use of its proprietary visualization technology, Odysight.ai offers solutions across predictive maintenance and condition-based monitoring markets, in sectors such as energy, automotive and aviation. Odysight.ai’s solutions are based on small and highly resilient cameras, specialized AI analysis and supplementary technologies. Some of the Company’s products utilize micro visualization technology in medical devices for minimally invasive medical procedures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since incorporation of Odysight.ai and through December 31, 2023, the Company accumulated a deficit of approximately $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20231231_zSu49GukfT63" title="Accumulated deficit">34.2</span> million and its activities have been funded mainly by its shareholders. The Company’s management believes the Company’ cash and cash resources will allow the Company to fund its operating plan through at least the next 12 months from the filing date of these Consolidated Financial Statements. However, the Company expects to continue to incur significant research and development and other costs related to its ongoing operations, requiring the Company to obtain additional funding in order to continue its future operations until becoming profitable.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>c.</b></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On October 7, 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets, which led Israel to formally declare war on Hamas the next day. The war is ongoing as of the issuance date of these financial statements. At this stage, the Company does not expect substantial impact of the above-described events on its operations.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.6pt; text-align: justify; text-indent: -49.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34200000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zTFwn96wN1Y2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zuv7SEgKRVma">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates its assumptions on an ongoing basis, including those related to contingencies and inventory impairment, as well as estimates used in applying its revenue recognition policy. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	SCTC	Monthly Salary Percentage MonthlySalaryPercentage	0.0833	pure
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	445000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	438000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	34000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	148000	usd
CY2023	us-gaap	Debt Instrument Term DebtInstrumentTerm	P12M
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	504000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	630000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1034000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1152000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	557000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	504000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	477000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	648000	usd
CY2023	us-gaap	Depreciation Depreciation	284000	usd
CY2022	us-gaap	Depreciation Depreciation	251000	usd
CY2023Q4	SCTC	Government Authorities GovernmentAuthorities	52000	usd
CY2023Q4	SCTC	Accrued Expenses Current AccruedExpensesCurrent	132000	usd
CY2022Q4	SCTC	Accrued Expenses Current AccruedExpensesCurrent	214000	usd
CY2023Q4	SCTC	Other Payables OtherPayables	27000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	211000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	214000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	25006000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	19239000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5786000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4564000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	5786000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	4564000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5786000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	25006000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	229000	usd
CY2022	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	117000	usd
CY2023	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	29000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1253554	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.31
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5884000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	479000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.50
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	172514	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.57
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1560040	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.64
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M1D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2116000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	986000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.15
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	90971	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.28
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2455069	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.46
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y14D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	312000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1163201	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.39
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y6M25D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	268000	usd
CY2023Q4	us-gaap	Share Price SharePrice	3
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.88	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.90	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0393	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0447	pure
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1664000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1638000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	665000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P7Y
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3033000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	665000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1256000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2322000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1675000	usd
CY2023	SCTC	Contract With Customer Asset Contract Costs ContractWithCustomerAssetContractCosts	-239000	usd
CY2022	SCTC	Contract With Customer Asset Contract Costs ContractWithCustomerAssetContractCosts	-180000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1256000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2420000	usd
CY2022	SCTC	Contract With Customer Liability Deferred Revenue Relating To New Sales ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales	1613000	usd
CY2023	SCTC	Contract With Customer Liability Revenue Recognized Development Services ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices	-1322000	usd
CY2022	SCTC	Contract With Customer Liability Revenue Recognized Development Services ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices	-389000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2322000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2300000	usd
CY2023	us-gaap	Variable Lease Payment VariableLeasePayment	7000	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	7000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1380000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1326000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	307000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	263000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	403000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	264000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	479000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	261000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M20D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M2D
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	572000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	528000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	403000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	156000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1659000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	333000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1326000	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	3561000	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	2034000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	521000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	576000	usd
CY2023	SCTC	Materials And Subcontractors MaterialsAndSubcontractors	767000	usd
CY2022	SCTC	Materials And Subcontractors MaterialsAndSubcontractors	1030000	usd
CY2023	us-gaap	Depreciation Nonproduction DepreciationNonproduction	164000	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	163000	usd
CY2023	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	41000	usd
CY2022	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	73000	usd
CY2023	SCTC	Vehicle Expenses VehicleExpenses	110000	usd
CY2022	SCTC	Vehicle Expenses VehicleExpenses	75000	usd
CY2023	SCTC	Rent And Maintenance And Other Expenses RentAndMaintenanceAndOtherExpenses	438000	usd
CY2022	SCTC	Rent And Maintenance And Other Expenses RentAndMaintenanceAndOtherExpenses	246000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5602000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4197000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1109000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	699000	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1132000	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1027000	usd
CY2023	SCTC	Share Based Compensation Included In General And Administartive Expenses ShareBasedCompensationIncludedInGeneralAndAdministartiveExpenses	994000	usd
CY2022	SCTC	Share Based Compensation Included In General And Administartive Expenses ShareBasedCompensationIncludedInGeneralAndAdministartiveExpenses	903000	usd
CY2023	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	1037000	usd
CY2022	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	859000	usd
CY2023	SCTC	Patents Patents	486000	usd
CY2022	SCTC	Patents Patents	292000	usd
CY2023	SCTC	Depreciation Included In General And Administartive Expenses DepreciationIncludedInGeneralAndAdministartiveExpenses	56000	usd
CY2022	SCTC	Depreciation Included In General And Administartive Expenses DepreciationIncludedInGeneralAndAdministartiveExpenses	34000	usd
CY2023	us-gaap	General Insurance Expense GeneralInsuranceExpense	182000	usd
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	337000	usd
CY2023	SCTC	Vehicle Expenses Included In General And Administartive Expenses VehicleExpensesIncludedInGeneralAndAdministartiveExpenses	100000	usd
CY2022	SCTC	Vehicle Expenses Included In General And Administartive Expenses VehicleExpensesIncludedInGeneralAndAdministartiveExpenses	73000	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	444000	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	181000	usd
CY2022	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-129000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4431000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3577000	usd
CY2023	SCTC	Royalties Agreement Description RoyaltiesAgreementDescription	Pursuant to the agreement with the IIA relating to the program, the Company has to pay royalties of 3% to the IIA up to the amount IIA funding received and the accrued interest repayment of the grant is contingent upon the Company successfully completing its enhancement plans and generating sales from the enhancements preformed
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	60000	usd

Files In Submission

Name	View Source	Status
0001493152-24-011341-index-headers.html	Edgar Link	pending
0001493152-24-011341-index.html	Edgar Link	pending
0001493152-24-011341.txt	Edgar Link	pending
0001493152-24-011341-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_01.jpg	Edgar Link	pending
form10-k_02.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sctc-20231231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sctc-20231231_def.xml	Edgar Link	unprocessable
sctc-20231231_lab.xml	Edgar Link	unprocessable
sctc-20231231_pre.xml	Edgar Link	unprocessable
sctc-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ODYS
Odysight.ai Inc. Stock $odys

2024 Q1 Form 10-K Financial Statement

#000149315224011341 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ODYS Odysight.ai Inc. Stock $odys

2024 Q1 Form 10-K Financial Statement

#000149315224011341 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ODYS
Odysight.ai Inc. Stock $odys